Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry)

被引:5
|
作者
Yoshikawa, Yusuke [1 ]
Yamashita, Yugo [1 ]
Morimoto, Takeshi [2 ]
Mabuchi, Hiroshi [3 ]
Amano, Hidewo [4 ]
Takase, Toru [5 ]
Hiramori, Seiichi [6 ]
Kim, Kitae [7 ]
Oi, Maki [8 ]
Akao, Masaharu [9 ]
Kobayashi, Yohei [10 ]
Toyofuku, Mamoru [11 ]
Izumi, Toshiaki [12 ]
Tada, Tomohisa [13 ]
Chen, Po-Min [14 ]
Murata, Koichiro [15 ]
Tsuyuki, Yoshiaki [16 ]
Saga, Syunsuke [17 ]
Nishimoto, Yuji [17 ]
Sasa, Tomoki [18 ]
Sakamoto, Jiro [19 ]
Kinoshita, Minako [20 ]
Togi, Kiyonori [21 ]
Takabayashi, Kensuke [22 ]
Shiomi, Hiroki [1 ]
Kato, Takao [1 ]
Makiyama, Takeru [1 ]
Ono, Koh [1 ]
Murakami, Tomoyuki [3 ]
Kimura, Takeshi [1 ]
机构
[1] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan
[2] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan
[3] Koto Mem Hosp, Dept Cardiol, Higashiomi, Japan
[4] Kurashiki Cent Hosp, Dept Cardiovasc Med, Kurashiki, Okayama, Japan
[5] Kinki Univ Hosp, Dept Cardiol, Osaka, Japan
[6] Kokura Mem Hosp, Dept Cardiol, Kokura, Japan
[7] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan
[8] Japanese Red Cross Otsu Hosp, Dept Cardiol, Otsu, Shiga, Japan
[9] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan
[10] Osaka Red Cross Hosp, Dept Cardiovasc Ctr, Osaka, Japan
[11] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan
[12] Kitano Hosp, Cardiovasc Ctr, Tazuke Kofukai Med Res Inst, Osaka, Japan
[13] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan
[14] Osaka Saiseikai Noe Hosp, Dept Cardiol, Osaka, Japan
[15] Shizuoka City Shizuoka Hosp, Dept Cardiol, Shizuoka, Japan
[16] Shimada Municipal Hosp, Div Cardiol, Shimada, Japan
[17] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan
[18] Kishiwada City Hosp, Dept Cardiol, Kishiwada, Japan
[19] Tenri Hosp, Dept Cardiol, Tenri, Nara, Japan
[20] Nishikobe Med Ctr, Dept Cardiol, Kobe, Hyogo, Japan
[21] Kinki Univ, Nara Hosp, Div Cardiol, Fac Med, Ikoma, Japan
[22] Hirakata Kohsai Hosp, Dept Cardiol, Hirakata, Osaka, Japan
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2020年 / 125卷 / 02期
关键词
ACUTE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; REAL-WORLD; RISK; PREVENTION; MANAGEMENT; DIAGNOSIS; POPULATION; GUIDELINES; OUTCOMES;
D O I
10.1016/j.amjcard.2019.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Statins, which are considered as essential for primary and secondary prevention of atherosclerotic diseases, were also reported to reduce first venous thromboembolism (VTE). However, the effect of statins on VTE recurrence remains conflicting. We aimed to examine the association between statin use and VTE recurrence in a large observational study in Japan. The COMMAND VTE Registry is a multicenter registry enrolling consecutive 3027 patients with acute symptomatic VTE in 29 centers in Japan between January 2010 and August 2014. In the current study, the entire cohort was divided into statin group (N = 437) and no-statin group (N = 2590) according to the status of statin use at baseline. The statin group as compared with the no-statin group was older (statin group 71.2 vs no-statin group 66.5 years, p<0.001), included more women (67% vs 60%, p = 0.008), and less frequently had active cancer (12% vs 25%, p<0.001). There was no significant difference in the clinical presentation of VTE (pulmonary embolism, 58% vs 56%, p = 0.44). The cumulative 3-year incidence of recurrent VTE was significantly lower in the statin group than the no-statin group (3.8% vs 8.8%, p<0.001). After adjusting for confounders including active cancer, statin use was associated with significantly lower risk for recurrent VTE (Hazard ratio 0.49, 95% confidence interval 0.29 to 0.78, p = 0.002). The results were consistent in a sensitivity sub-group analysis with and without active cancer. In conclusion, statin use was associated with significantly lower risk for the recurrent VTE in patients with VTE. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 50 条
  • [31] Venous thromboembolism (VTE) and glioblastoma
    Yust-Katz, Shlomit
    Mandel, Jacob J.
    Wu, Jimin
    Yuan, Ying
    Webre, Courtney
    Pawar, Tushar A.
    Lhadha, Harshad S.
    Gilbert, Mark R.
    Armstrong, Terri S.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (01) : 87 - 94
  • [32] Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry
    Garcia-Ortega, Alberto
    Lopez-Reyes, Raquel
    Anguera, Gabriel
    Oscullo, Grace
    Rivas, Agustina
    Lopez-Jimenez, Luciano
    Lorenzo, Alicia
    Mahe, Isabelle
    Ciammaichella, Maurizio
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2021, 201 : 131 - 138
  • [33] Recurrent Venous Thromboembolism
    Mount, Hillary R.
    Rich, Megan
    Putnam, Michael S.
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (04) : 377 - 385
  • [34] Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH)
    Kananeh, Mohammed F.
    Fonseca-Paricio, Mario J.
    Liang, John W.
    Sullivan, Lindsay T.
    Sharma, Kumud
    Shah, Syed Omar
    Vibbert, Matthew D.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (02):
  • [35] Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism
    Klok, Frederikus A.
    Presles, Emilie
    Tromeur, Cecile
    Barco, Stefano
    Konstantinides, Stavros V.
    Sanchez, Olivier
    Pernod, Gilles
    Raj, Leela
    Robin, Philippe
    Le Roux, Pierre-Yves
    Hoffman, Clement
    Melac, Solen
    Bertoletti, Laurent
    Girard, Philippe
    Laporte, Silvy
    Mismetti, Patrick
    Meyer, Guy
    Leroyer, Christophe
    Couturaud, Francis
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (03) : 364 - 371
  • [36] Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study
    Baumgartner, Christine
    Go, Alan S.
    Fan, Dongjie
    Sung, Sue Hee
    Witt, Daniel M.
    Schmelzer, John R.
    Williams, Marc S.
    Yale, Steven H.
    VanWormer, Jeffrey J.
    Fang, Margaret C.
    THROMBOSIS RESEARCH, 2020, 189 : 112 - 118
  • [37] Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer-VTE Registry)
    Ikeda, Masataka
    Uetake, Hiroyuki
    Yoshino, Takayuki
    Hata, Taishi
    Oba, Mari S.
    Takita, Atsushi
    Kimura, Tetsuya
    CANCER SCIENCE, 2022, 113 (11) : 3901 - 3911
  • [38] Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE)
    Bikdeli, Behnood
    Jimenez, David
    Hawkins, Mayra
    Ortiz, Salvador
    Prandoni, Paolo
    Brenner, Benjamin
    Decousus, Herve
    Masoudi, Frederick A.
    Trujillo-Santos, Javier
    Krumholz, Harlan M.
    Monreal, Manuel
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 214 - 224
  • [39] Metabolomic Profile in Venous Thromboembolism (VTE)
    Franczyk, Beata
    Gluba-Brzozka, Anna
    Lawinski, Janusz
    Rysz-Gorzynska, Magdalena
    Rysz, Jacek
    METABOLITES, 2021, 11 (08)
  • [40] Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry
    Nishimoto, Yuji
    Yamashita, Yugo
    Morimoto, Takeshi
    Saga, Syunsuke
    Amano, Hidewo
    Takase, Toru
    Hiramori, Seiichi
    Kim, Kitae
    Oi, Maki
    Akao, Masaharu
    Kobayashi, Yohei
    Toyofuku, Mamoru
    Izumi, Toshiaki
    Tada, Tomohisa
    Chen, Po-Min
    Murata, Koichiro
    Tsuyuki, Yoshiaki
    Sasa, Tomoki
    Sakamoto, Jiro
    Kinoshita, Minako
    Togi, Kiyonori
    Mabuchi, Hiroshi
    Takabayashi, Kensuke
    Shiomi, Hiroki
    Kato, Takao
    Makiyama, Takeru
    Ono, Koh
    Sato, Yukihito
    Kimura, Takeshi
    HEART AND VESSELS, 2019, 34 (04) : 669 - 677